Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology
About Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Ethicare GmbH
3
Xeltis
2
Abbott Medical Devices
1
Javelin Medical
1
Pi-cardia
1
ZOLL Circulation, Inc., USA
1
Clinical Trials at Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology
During the past decade, Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
2010-05-01
2015-05-01
Completed
1,170
Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
2016-01-01
2017-06-01
Unknown status
50
Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease
2016-01-01
2017-06-01
Unknown status
50
Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
2016-03-01
2018-04-01
Unknown status
100
Study to Assess Safety of the Pulmonary Valved Conduit (PV-001) in Subjects Undergoing Right Ventricular Outflow Tract Reconstruction
2016-06-01
2022-04-01
Unknown status
12
Xeltis Pulmonary Valved Conduit Safety and Performance Study
2020-09-01
2026-10-01
Withdrawn
0
Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
2019-05-13
2024-10-24
Active, not recruiting
100
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" #1 sponsor was "Ethicare GmbH" with 3 trials, followed by "Xeltis" with 2 trials
sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Javelin Medical" with 1 trials sponsored and "Pi-cardia"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology"
#1 collaborator was "Genae" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology
According to Clinical.Site data, the most researched conditions in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" are
"Congenital Heart Disease" (3 trials), "Heart Failure" (3 trials), "Dilated Cardiomyopathy" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" in a lesser frequency.
Clinical Trials Intervention Types at Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology
Most popular intervention types in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" are "Device" (4 trials), "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Enalapril Orodispersible Minitablet" (3 trials), "Bioabsorbable Pulmonary Valved Conduit (PV-001)" (1 trials), "Leaflex™ Performer" (1 trials), "OMT" (1 trials) and "Standard of care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology
The vast majority of trials in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" are
9 trials for "All" genders.
Clinical Trials Status at Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology
Currently, there are NaN active trials in "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".